These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 8213878

  • 21. Rational design, conformational studies and bioactivity of highly potent conformationally constrained calcitonin analogues.
    Kapurniotu A, Kayed R, Taylor JW, Voelter W.
    Eur J Biochem; 1999 Oct; 265(2):606-18. PubMed ID: 10504392
    [Abstract] [Full Text] [Related]

  • 22. Comparison of cyclic and continuous calcitonin regimens in the treatment of postmenopausal osteoporosis.
    Tekeoğlu I, Adak B, Budancamanak M, Demirel A, Ediz L.
    Rheumatol Int; 2005 Dec; 26(2):157-61. PubMed ID: 15660234
    [Abstract] [Full Text] [Related]

  • 23. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.
    Tascioglu F, Colak O, Armagan O, Alatas O, Oner C.
    Rheumatol Int; 2005 Nov; 26(1):21-9. PubMed ID: 15688191
    [Abstract] [Full Text] [Related]

  • 24. Antibodies against calcitonins as a source of analytical errors.
    Dorizzi RM, Tagliaro F, Ghielmi S, Archetti S, Poiesi C, Luisetto G.
    Eur J Clin Chem Clin Biochem; 1991 Oct; 29(10):689-9. PubMed ID: 1764544
    [No Abstract] [Full Text] [Related]

  • 25. Biological properties of salmon calcitonin IV.
    Schecroun N, Pidoux E, Horne WC, Hernandez-Lagunas L, Baron R, Cressent M.
    J Bone Miner Res; 1999 Aug; 14(8):1425-31. PubMed ID: 10457276
    [Abstract] [Full Text] [Related]

  • 26. [Synthetic salmon calcitonin suppositories for the short-term treatment of involutive osteoporosis].
    Isaia GC, Di Stefano M, Sciolla A, Mussetta M, Vassellatti D.
    Minerva Med; 1995 Mar; 86(3):101-4. PubMed ID: 7603605
    [Abstract] [Full Text] [Related]

  • 27. Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover.
    Tankó LB, Bagger YZ, Alexandersen P, Devogelaer JP, Reginster JY, Chick R, Olson M, Benmammar H, Mindeholm L, Azria M, Christiansen C.
    J Bone Miner Res; 2004 Sep; 19(9):1531-8. PubMed ID: 15312255
    [Abstract] [Full Text] [Related]

  • 28. Synthesis and Biological Activity of Human Calcitonin Analogue.
    Yu C, Zhou GM, Li BL, Wu XF, Cui DF.
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 1999 Sep; 31(5):553-557. PubMed ID: 12114969
    [Abstract] [Full Text] [Related]

  • 29. [Asu(1,7)E-CT, an analog of eel calcitonin. A comparative study in man with reference to other synthetic calcitonins].
    Caniggia A, Nuti R, Vattimo A, Galli M, Turchetti V, Franci B, Martorelli T, Righi G.
    Minerva Med; 1983 Apr 28; 74(18):993-1010. PubMed ID: 6087215
    [Abstract] [Full Text] [Related]

  • 30. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
    Houssami S, Findlay DM, Brady CL, Martin TJ, Epand RM, Moore EE, Murayama E, Tamura T, Orlowski RC, Sexton PM.
    Mol Pharmacol; 1995 Apr 28; 47(4):798-809. PubMed ID: 7723741
    [Abstract] [Full Text] [Related]

  • 31. Response of Paget's disease to human calcitonin in patients resistant to porcine calcitonin.
    Lo Cascio V, Adami S, Galvanini G, Lazzaretto R, Ferrari M, Tartarotti D, Scuro LA.
    J Endocrinol Invest; 1984 Apr 28; 7(2):85-8. PubMed ID: 6725870
    [Abstract] [Full Text] [Related]

  • 32. Porcine calcitonin in the treatment of Paget's disease of bone: experience with 32 patients.
    Plehwe WE, Hudson J, Clifton-Bligh P, Posen S.
    Med J Aust; 1977 Apr 16; 1(16):577-81. PubMed ID: 559908
    [Abstract] [Full Text] [Related]

  • 33. Two-site immunoradiometric assay of intact salmon calcitonin.
    Deftos LJ.
    Clin Chem; 1992 Nov 16; 38(11):2284-6. PubMed ID: 1385017
    [Abstract] [Full Text] [Related]

  • 34. Synthetic human calcitonin: analysis of antibodies obtained from various animal species and determination of immunoreactive hormone in human sera.
    Dietrich FM, Hunziker WH, Fischer JA.
    Acta Endocrinol (Copenh); 1975 Nov 16; 80(3):465-86. PubMed ID: 1242563
    [Abstract] [Full Text] [Related]

  • 35. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E, Lyritis GP, Kosmidis C, Galanos A, Andypas G, Chorianopoulos K, Giagiosis A, Iliadou K, Karagianis A, Katsimichas K, Koskinas A, Matsouka K.
    Clin Rheumatol; 2005 Jun 16; 24(3):232-8. PubMed ID: 15647969
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A chimeric analog of human and salmon calcitonin eliminates antigenicity and reduces gastrointestinal disturbances.
    Kozono T, Hirata M, Endo K, Satoh K, Takanashi H, Miyauchi T, Fukushima N, Kumagai E, Abe S, Matsuda E.
    Endocrinology; 1992 Dec 16; 131(6):2885-90. PubMed ID: 1280207
    [Abstract] [Full Text] [Related]

  • 38. Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin.
    Rojanasathit S, Rosenberg E, Haddad JG.
    Lancet; 1974 Dec 14; 2(7894):1412-5. PubMed ID: 4140329
    [No Abstract] [Full Text] [Related]

  • 39. Synthesis, characterization and evaluation of bone targeting salmon calcitonin analogs in normal and osteoporotic rats.
    Bhandari KH, Newa M, Chapman J, Doschak MR.
    J Control Release; 2012 Feb 28; 158(1):44-52. PubMed ID: 22001608
    [Abstract] [Full Text] [Related]

  • 40. Radioimmunoassay of human calcitonin using labeled [Asu1, 7]-human calcitonin analogue.
    Okada Y, Morimoto S, Onishi T, Tanaka K, Tsuji M, Kumahara Y, Tsushima S, Nakazawa N, Ogawa H, Sakakibara S.
    Endocrinol Jpn; 1978 Dec 28; 25(6):617-22. PubMed ID: 751807
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.